Home/Filings/4/A/0001171843-15-006796
4/A//SEC Filing

IMMUNOMEDICS INC 4/A

Accession 0001171843-15-006796

CIK 0000722830operating

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 5:00 PM ET

Size

18.8 KB

Accession

0001171843-15-006796

Insider Transaction Report

Form 4/AAmended
Period: 2015-12-01
Stark Don C
Director
Transactions
  • Award

    Stock Options (right to buy)

    2015-12-02+28,82128,821 total
    Exercise: $3.11Exp: 2022-12-02Common Stock, par value $0.01 per share (28,821 underlying)
  • Award

    Restricted Stock Units

    2015-12-02+14,46914,469 total
    Common Stock, par value $0.01 per share (14,469 underlying)
  • Sale

    Common Stock

    2015-12-01$3.15/sh5,100$16,09045,350 total
  • Exercise/Conversion

    Common Stock

    2015-12-01$1.59/sh+10,000$15,90050,450 total
  • Exercise/Conversion

    Common Stock

    2015-12-01+10,66456,014 total
  • Tax Payment

    Common Stock

    2015-12-014,26651,748 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-12-0110,0000 total
    Exercise: $1.59Exp: 2015-12-03Common Stock, par value $0.01 per share (10,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2015-12-0110,6640 total
    Common Stock, par value $0.01 per share (10,664 underlying)
Footnotes (5)
  • [F1]Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014.
  • [F2]The purpose of this amendment is to correct the number of shares withheld to satisfy the tax withholding obligation of the reporting person reported in the Form 4 filed on December 4, 2015.
  • [F3]The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage.
  • [F4]The stock options are fully vested on the date of grant.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000722830

Filing Metadata

Form type
4/A
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:00 PM ET
Size
18.8 KB